Defunct Company
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
NCT03801889
SP-420 in Subjects With Transfusion-dependent Beta-Thalassemia or Other Rare Anemias
Phase: Phase 2
Role: Lead Sponsor
Start: Aug 31, 2020
Completion: Jan 31, 2023
NCT04741542
Safety of SP-420 in the Treatment of Transfusional Iron Overload
Phase: Phase 1
Role: Collaborator
Start: Mar 9, 2021
Completion: Jan 10, 2024